Answer from: Medical Oncologist at Community Practice
Cisplatin-based chemoradiotherapy continues to be the standard. I personally use 100 mg/m2 every 3 weeks, since it’s the only regimen with randomized phase 3 data. However, I think there is likely no difference on the outcome when using 40 mg/m2 weekly in the adjuvant setting if the dose inten...
Thanks. I saw the Cooper study from 2004 using 3 w...